Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual.
about
Genotypes and haplotypes of the methyl-CpG-binding domain 2 modify breast cancer risk dependent upon menopausal statusSentinel Lymph Node in Breast Cancer: Review Article from a Pathologist's Point of ViewRacial and ethnic differences in risk of second primary cancers among breast cancer survivorsThe Significance of Long Noncoding RNA H19 in Predicting Progression and Metastasis of Cancers: A Meta-AnalysisPrognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based reviewAnnexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study.Metastatic axillary node ratio predicts recurrence and poor long-term prognosis in patients with advanced stage IIIC (pN3) breast cancerMicrorna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer.Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer.Diagnosis delay of breast cancer and its associated factors in Malaysian women.Association of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women.Long-term survival analysis of korean breast cancer patients at a single center: improving outcome over time.KISS1 methylation and expression as predictors of disease progression in colorectal cancer patientsTechnology as a force for improved diagnosis and treatment of breast disease.Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancerPhosphorylation of focal adhesion kinase at Tyr397 in gastric carcinomas and its clinical significance.Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity.Survival differences among women with de novo stage IV and relapsed breast cancer.Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership.MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene.Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer.A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancerThe effects of applying breast compression in dynamic contrast material-enhanced MR imagingMicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.Down-regulation of c9orf86 in human breast cancer cells inhibits cell proliferation, invasion and tumor growth and correlates with survival of breast cancer patientsGene signatures of breast cancer progression and metastasis.Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth.Circulating tumor cells in newly diagnosed inflammatory breast cancer.Race is not a factor in overall survival in patients with triple negative breast cancer: a retrospective review.Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer.Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer.Prognostic value of the lymph node ratio for lymph-node-positive breast cancer- is it just a denominator problem?Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017.Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysisInitial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancerMucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristics and prognosisPromoter Methylation of the Retinoic Acid Receptor Beta2 (RARβ2) Is Associated with Increased Risk of Breast Cancer: A PRISMA Compliant Meta-Analysis.Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors.
P2860
Q24813574-6C449C62-9B99-4645-8C8D-84913BEC1DB6Q26772240-54E7615E-0AC7-428D-8864-0042E2BAA386Q27317129-CAE4BA6C-2735-4A53-AFAB-E530D6FE0001Q28076788-EB71DF88-4E88-4633-8545-3B61380B1757Q33561966-185E7889-33F2-4468-9ADA-080662ED3698Q33608061-2FAA1E7E-EBBF-4A74-85E5-9FFDB45F5CD9Q33636187-4FEBA29C-0157-45BD-8142-174E6228E0FDQ33643578-BB7BB6F8-0465-411E-9211-42586FCE7FD5Q33829270-50B31D8A-F985-40C1-BB67-BAC5F4E0F508Q33874463-F37DBDC4-D608-4C56-A4B7-883EF020C96AQ33904564-DC02A20F-E4E4-4418-A529-BC797E66F73CQ33941558-26CBEC60-1B45-4EAA-B339-CA73111B6E09Q34008651-1E0524FA-23F0-4F5C-BE47-490B3FD80FAEQ34027986-A015FA68-E88C-43EA-91C4-E0D19A1F000AQ34029232-0D855B67-FDE4-4BA4-BDB3-B018EEE0B54DQ34088277-C6E397B5-E8F6-4F57-981E-B13897741B27Q34162284-88C49D6A-EAF0-4DB6-B475-54A40D40C3A3Q34197501-4167D32F-8B60-451A-9551-E777DB041E6DQ34231099-D74D2706-7192-4E8F-AA46-0E824D8E0575Q34279558-F07412A2-A396-4AC0-B964-8E75D02B8602Q34284590-674265F8-D790-4D07-B394-B4875B8FEDC9Q34328025-667C69AB-EBD5-49E2-9A1C-63EDCB54D5FFQ34506546-263B1CA4-5F66-42D9-9303-14159A39FC32Q34681250-95995A56-0755-43A3-9782-4A7164533AD3Q34835189-95976C5F-F29A-4781-8127-91BFD94801A4Q34972178-1108FAB1-2F3E-4DE3-AD12-5962DF550D94Q35029477-5B4B8C3C-6ACF-43A5-ADCE-6888F8BA96B3Q35029501-0E4EBC37-4E87-4DAD-9013-F6F0526C819DQ35052773-2FEE4A7E-AEA9-4DC8-B706-1E8CD6AEF8D2Q35059135-35B4CA1A-7A9C-47B9-A65F-25F2C9344857Q35114444-87556CAB-7434-452F-8DA2-96E266DE63FBQ35172721-8481E1DC-6C00-4676-8A39-808D8D6EAD1BQ35196745-596B2239-D9F3-495F-8186-F243494C4E0DQ35207932-6FFF92A1-BB02-42B0-9F9F-9D517CEB6E9DQ35221922-87541C79-A85B-4ECD-8798-BDCCE55ED5D8Q35584408-AB65DDA4-6E8C-4ED2-A678-9ED43546F676Q35584948-9469EE85-444D-4EC1-BD88-3B5902CE0597Q35713864-726B062E-61A8-4704-B68C-E151976C1A29Q35801560-9F8BEE0A-50A1-4D0B-BF9E-0B7A804528EDQ35808400-33D7EEC6-48D6-4CE7-9E7C-05FF9264EDBC
P2860
Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Staging system for breast canc ...... he AJCC Cancer Staging Manual.
@ast
Staging system for breast canc ...... he AJCC Cancer Staging Manual.
@en
type
label
Staging system for breast canc ...... he AJCC Cancer Staging Manual.
@ast
Staging system for breast canc ...... he AJCC Cancer Staging Manual.
@en
prefLabel
Staging system for breast canc ...... he AJCC Cancer Staging Manual.
@ast
Staging system for breast canc ...... he AJCC Cancer Staging Manual.
@en
P2093
P1476
Staging system for breast canc ...... he AJCC Cancer Staging Manual.
@en
P2093
Abram Recht
Craig Allred
Daniel F Hayes
David L Page
Donald Berry
Donald L Weaver
Frederick L Greene
Gary M Clark
H Samuel Wieand
P304
P356
10.1016/S0039-6109(03)00034-3
P577
2003-08-01T00:00:00Z